Keyphrases
Acquired Hemophilia A
7%
Am(III)
7%
Aplastic Anemia
7%
Atypical Hemolytic Uremic Syndrome (aHUS)
7%
Autoimmune Hemolytic Anemia
7%
Autoimmune Neutropenia
7%
Blood Products
7%
Blood Services
7%
Canada
28%
Clinical Opinion
7%
Draft Guideline
7%
Evidence-based Approach
7%
Evidence-based Guidelines
7%
Evidence-based Practice Guidelines
7%
Evidence-based Review
7%
Expert Panel
21%
Guideline Development
7%
Hematologic
100%
Hematologist
7%
Hematopoietic Stem Cell Transplantation
7%
Hemolytic Disease of the Newborn
7%
Hemolytic Transfusion Reaction
14%
Hemophagocytic Syndrome
7%
Heparin-induced Thrombocytopenia
7%
HIV-associated
7%
Hypogammaglobulinemia
7%
Inappropriate Use
7%
Intravenous Immunoglobulin (IVIg)
100%
Life-threatening
7%
Malignancy
7%
Medical Experts
7%
Ministry of Health
7%
National Committee
7%
National Experts
7%
Neonatal Alloimmune Thrombocytopenia
7%
Off-label Use
7%
Posttransfusion Purpura
7%
Practice Guidelines
21%
Practice of Medicine
7%
Pure Red Cell Aplasia
7%
Sickle Cell Disease
7%
Territorial Health
7%
Thrombocytopenia
7%
Thrombotic Thrombocytopenic Purpura
14%
Usage Management
7%
Viral
7%
Von Willebrand Disease
7%
Medicine and Dentistry
Aplastic Anemia
7%
Atypical Hemolytic Uremic Syndrome
7%
Autoimmune neutropenia
7%
Blood Disorder
100%
Blood Product
7%
Blood Transfusion Reaction
14%
Cancer
7%
Evans Syndrome
7%
Haemophilia A
7%
Head
14%
Hematopoietic Stem Cell Transplantation
7%
Hemolytic Anemia
7%
Hemophagocytic Syndrome
7%
Heparin-Induced Thrombocytopenia
7%
Human Immunodeficiency Virus
7%
Hypogammaglobulinemia
7%
Idiopathic Thrombocytopenic Purpura
7%
Immunoglobulin
100%
Medicine
7%
Neonatal Alloimmune Thrombocytopenia
7%
Neonatal Infant
7%
Pure Red Cell Aplasia
7%
Purpura
7%
Sickle-Cell Disease
7%
Thrombocytopenia
7%
Thrombotic Thrombocytopenic Purpura
7%
Von Willebrand Disease
7%